CC
VIRX
Caxton Corporation’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-8,134,926
| Closed | -$3.38M | – | 20 |
|
|
2020
Q1 | $3.38M | Hold |
8,134,926
| – | – | 3.69% | 7 |
|
|
2019
Q4 | $2.75M | Buy |
8,134,926
+2,789,100
| +52% | +$942K | 2.65% | 9 |
|
|
2019
Q3 | $3.85M | Buy |
5,345,826
+2,700,000
| +102% | +$1.94M | 4.34% | 9 |
|
|
2019
Q2 | $1.92M | Buy |
2,645,826
+2,368,581
| +854% | +$1.72M | 2.18% | 11 |
|
|
2019
Q1 | $337K | Buy |
+277,245
| New | +$337K | 0.31% | 14 |
|
|
2018
Q4 | – | Sell |
-111,217
| Closed | -$222K | – | 30 |
|
|
2018
Q3 | $222K | Buy |
111,217
+62,510
| +128% | +$125K | 0.21% | 25 |
|
|
2018
Q2 | $103K | Buy |
+48,707
| New | +$103K | 0.04% | 21 |
|
|
2015
Q3 | – | Sell |
-47,814
| Closed | -$144K | – | 22 |
|
|
2015
Q2 | $144K | Buy |
+47,814
| New | +$144K | 0.15% | 18 |
|